Jun 22, 2020
Cellular Biomedicine Group (CBMG) Presents Poster of TCRs Targeting AFP-Positive Liver Cancer at AACR Annual Meeting
Jun 22, 2020
twoXAR Pharmaceuticals Presents Positive Preclinical Safety and Efficacy Data for its Novel Investigational Cancer Treatment TXR-311
May 13, 2020
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
May 06, 2020
FDA Grants MIV-818 Orphan Drug Designation for the Treatment of Hepatocellular Carcinoma
Apr 30, 2020
Medivir Receives Positive Opinion on Orphan Medicinal Drug Designation by the European Medicines Agency for MIV-818
Apr 28, 2020
The Global Tumor Ablation Market is expected to grow from USD 473.95 Million in 2018 to USD 1,649.04 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 19.49%
Apr 03, 2020
Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market
Mar 10, 2020
First Liver Cancer Patient Dosed in the MIV-818 Phase Ib Study
Feb 17, 2020
Ascletis' IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA
Jan 06, 2020
CStone Pharmaceuticals and Blueprint Medicines Initiate Phase 1b/2 Clinical Trial of Fisogatinib in Combination with CS1001 for Patients with Hepatocellular Carcinoma
Nov 18, 2019
Medivir Reports Last Patient Recruited to the Phase Ia Study of MIV-818 in Liver Cancer Patients and Initial Dose Determined for phase Ib
Nov 12, 2019
Laboratory for Advanced Medicine Presents New Liver Cancer Test Data at The Liver Meeting 2019
Nov 06, 2019
DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results
Oct 30, 2019
Medivir Presents MIV-818 Data at AACR-NCI-EORTC in Boston
Oct 22, 2019
OrigiMed: The largest cohort study on HBV-Related hepatocellular carcinoma in China released in Cell
Aug 22, 2019
Snap Bio's Lead Candidate Overcomes Resistance of Approved Drugs for Liver Cancer
Aug 20, 2019
Q BioMed and Collaborator Chemveda Life Sciences Announce Potential Chemotherapeutic Breakthrough in Liver Cancer
Jun 13, 2019
Selective Effect Signal on Liver Cancer Tissue in Phase Ia Study With MIV-818
Jun 11, 2019
HistoSonics, Non-Invasive Robotics Pioneer, Releases Promising Data at Society of Interventional Oncology (SIO)
Jun 05, 2019
CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC